Center for Infectious Disease Research And Policy
 Home  _  Mission & Activities  _  About Us  _  Center Support  _  Contact Us 
 
Influenza
  
_
General Info/
Vaccines
Influenza
  
_
Avian Flu
Influenza
  
_
Pandemic Flu
  _ _
   _    News
  _ _
   _    Overview
  _ _
   Current item    Selected Reading
  _ _
   _    Guidelines
  _ _
   _    More Links
  _ _
Influenza
  
_
Business Planning
Influenza
Bioterrorism
  
_
General Info
Bioterrorism
  
_
Anthrax
Bioterrorism
  
_
Botulism
Bioterrorism
  
_
Plague
Bioterrorism
  
_
Smallpox
Bioterrorism
  
_
Tularemia
Bioterrorism
  
_
VHF
Bioterrorism
Biosecurity
  
_
Agriculture
Biosecurity
  
_
Food
Biosecurity
Food Safety
  
_
General Info
Food Safety
  
_
Irradiation
Food Safety
  
_
Foodborne Disease
Food Safety
Other Topics
  
_
BSE & vCJD
Other Topics
  
_
SARS
Other Topics
  
_
West Nile
Other Topics
  
_
Monkeypox
Other Topics
  
_
Chemical Terrorism
Other Topics
_
_
Influenza

INFLUENZA >>  PANDEMIC INFLUENZA >> 

_
Selected Reading  

* Abramovich MN, Toner ES, Matheny J. Panalysis: a new spreadsheet-based tool for pandemic planning. Biosecur Bioterror 2008 Mar;6(1):78-92 [Full text]

* Acambis. Acambis enters flu vaccine arena with launch of flu vaccine development programme. Aug 4, 2005 [Full Text]

* ACEP (American College of Emergency Physicians). The national report card on the state of emergency medicine: evaluating the environment of emergency care systems state by state. Jan 2006 [Full text]

* ACLU (American Civil Liberties Union). Pandemic preparedness: the need for a public health--not a law enforcement/national security--approach. Jan 14, 2008 [Full text]

* ACP. The health care response to pandemic influenza. Position paper from the American College of Physicians. 2006 [Full text]

* Adini B, Goldberg A, Cohen R, et al. Relationship between standards of procedures for pandemic flu and level of hospital performance in simulated drills. Ann Emerg Med 2008 (published online May 13) [Abstract]

* Albright FS, Orlando P, Pavia AT, et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007) [Full text]

* Alexander ME, Bowman CS, Feng Z, et al. Emergence of drug resistance: implications for antiviral control of pandemic influenza. Proc R Soc B 2007 (published online May 16) [Abstract]

* Alford RH, Kasel JA, Gerone PJ, et al. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966 Jul;122(3):800-4

* American Council on Science and Health. Avian influenza, or bird flu: what you need to know. Mar 2006 [Full text]

* American Health Lawyers Association. Community pan-flu preparedness: a checklist of key legal issues for healthcare providers. Jul 2008 [Full text]

* Anantham D, McHugh W, O'Neill S, et al. Clinical review: Influenza pandemic--physicians and their obligations. Crit Care 2008;12(3):217 (published online Jun 24) [Abstract]

* Andreasen V, Viboud C, Simonsen l. Epidemiologic characterization of the 1918 pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008 Jan 15;192(2):270-8 [Abstract]

* Anikeeva O, Braunack-Mayer AJ, Street JM. How will Australian general practitioners respond to an influenza pandemic? a qualitative study of ethical values. Med J Aust 2008 Aug 4;189(3):148-50 [Abstract]

* APHA (American Public Health Association). APHA's prescription for pandemic flu. Released Feb 22, 2007 [Full text]

* Apisarnthanarak A, Warren DK, Fraser VJ. Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries. Clin Infect Dis 2007 Nov 15;45(10):1338-42 [Abstract]

* Arinaminpathy N, McLean AR. Antiviral treatment for the control of pandemic influenza: some logistical constraints. J R Soc Interface 2007 (published online Aug 28) [Abstract]

* Arizona Department of Health Services. Modern Methods for Influenza Detection and Sub-typing [PowerPoint presentation]

* ASTHO, APHL, CSTE, NACCHO. Public health emergency preparedness: six years of achievement. Sep 29, 2008 [Full text]

* ASTHO. At-risk populations and pandemic influenza: planning guidance for state, territorial, tribal, and local health departments. Released Jun 30, 2008 [Home page, with link to full-text PDF]

* ASTHO. Nature's terrorist attack: pandemic influenza. Preparedness planning for state health officials. Nov 2002 [Full text]

* Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135?42 [Abstract]

* Attaran A. A legislative failure of epidemic proportions. (Editorial) CMAJ 2008 Jul 1;179(1) (published online Jun 12) [Full text]

* Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 2007 Sep;81(18):9950-5 [Abstract]

* Australian Department of Health and Ageing. National pandemic influenza exercise: Exercise Cumpston 06 report. Released Jun 7, 2007 [Full text]

* Avery GH, Lawley M, Garrett S, et al. Planning for pandemic influenza: lessons from the experiences of thirteen Indiana counties. J Homeland Secur Emerg Manage 2008;5(1):29 (published online Jul 2) [Abstract]

* Ayora-Talavera G, Cadavieco-Burgos JM, Canul-Armas AB. Serologic evidence of human and swine influenza. Emerg Infect Dis 2005 Jan;11(1):158-60 [Full text]

* Balicer RD, Huerta M, Davidovitch N, et al. Cost-benefit of stockpiling drugs for influenza pandemic. Emerg Infect Dis 2005 Aug;11(8) [Full text]

* Balicer RD, Omer SB, Barnett SB, et al. Local public health workers' perceptions toward responding to an influenza pandemic. BMC Pub Health 2006 (Published online Apr 18) [Full text]

* Baras B, Stittelaar KJ, Simon JH, et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE 2008 Jan 2;3(1):e1401 [Full text]

* Barnett DJ, Balicer RD, Lucey DR, et al. A systematic analytic approach to pandemic influenza preparedness planning. PLoS Med 2005 Dec;2(12) [Full text]

* Barr M, Raphael B, Taylor M, et al. Pandemic influenza in Australia: using telephone surveys to measure perceptions of threat and willingness to comply. BMC Infect Dis 2008;8:117 (published online Sep 15) [Abstract]

* Barrett R, Brown PJ. Stigma in the time of influenza: social and institutional responses to pandemic emergencies. J Infect Dis 2008 Feb 15;197(S1):S34-7 [Abstract]

* Barry JM, Viboud C, Simonsen L. Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain. J Infect Dis 2008 (published online Sep 22) [Abstract]

* Barry JM. 1918 revisited: lessons and suggestions for further inquiry. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004 [Full text]

* Barry JM. Nonpharmaceutical interventions implemented during the 1918-1919 influenza pandemic. (Letter) JAMA 2007 Nov 21;298(19):2260-1 [Extract]

* Bartlett JG, Borio L. The current status of planning for pandemic influenza and implications for health care planning in the United States. Clin Infect Dis 2008;46 (published online Feb 14) [Abstract]

* Bartlett JG. Planning for avian influenza. Ann Intern Med 2006 Jul 18;145(2) (published online Jun 27) [Full text]

* Basler CF, Aguilar PV. Progress in identifying virulence determinants of the 1918 H1N1 and Southeast Asian H5N1 influenza viruses. Antiviral Res 2008 Sep;78(3):166-78 [Abstract]

* Baylor NW. Regulatory issues: pandemic preparedness pacing up. BioPharm Int 2007 Aug (supp) (published online Aug 2) [Full text]

* Bean B, Moore BM, Sterner B, at al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982 Jul;146(1):47-51 [Astract]

* Beaton R, Stergachis A, Thompson J, et al. Pandemic policy and planning considerations for universities: findings from a tabletop exercise. Biosecur Bioterror 2007 Dec;5(4):327-34 [Abstract]

* Beaumont M, Duggal HV, Mahmood H, et al. A survey of the preparedness for an influenza pandemic of general practitioners in the West Midlands, UK. Eur J Clin Microbiol Infect Dis 2007 (published online Aug 10) [Abstract]

* Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102 [Abstract]

* Belser JA, Lu X, Szretter KJ, et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 2007 Nov 15;196(10):1493-9 [Abstract]

* Belshe RB. The origins of pandemic influenza: lessons from the 1918 virus. N Engl J Med 2005 Nov 24;353(21):2209-11 [Full text]

* Berkman BE. Mitigating pandemic influenza: the ethics of implementing a school closure policy. J Publ Health Manag Pract 2008 Jul-Aug;14(4):372-8 [Abstract]

* Blendon RJ, Koonin LM, Benson JM, et al. Public response to community mitigation measures for pandemic influenza. Emerg Infect Dis 2008 May (published online Mar 28) [Full text]

* Bloomfield S, Exner M, Fara GM, et al. Prevention of the spread of infection - the need for a family-centred approach to hygiene promotion. Eurosurveillance 2008 May 29;13(22) [Full text]

* Blue Ribbon Commission on Mega-Catastrophes. Preparing for pandemic flu: a call to action. From Financial Services Roundtable. Nov 1, 2006 [Full text]

* Blumenshine P, Reingold A, Egerter S, et al. Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis 2008 May (published online Mar 28) [Full text]

* Bogner P, Capua I, Cox, NJ, et al. A global initiative on sharing avian flu data. Nature 2006 (Published online Aug 24) [Full text]

* Bootsma CJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in US cities. Proc Natl Acad Sci 2007 (published online Apr 6) [Abstract, with access to free full text]

* Booy R, Brown LE, Grohmann GS, et al. Pandemic vaccines: promises and pitfalls. Med J Aust 2006 Nov 20;185(10 suppl):S62-5 [Full text]

* Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31 [Abstract]

* Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses transmit efficiently among guinea pigs by direct contact but not by aerosol. J Virol 2008 Oct;82(20):10052-8 [Abstract]

* Boyd M, Clezy K, Lindley R, et al. Pandemic influenza: clinical issues. Med J Aust 2006 Nov 20;185(10 suppl):S44-7 [Full text]

* Brankston G, Gitterman L, Hirji A, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007, published online Feb 19 [Abstract]

* Branson RD, Johannigman JA, Daugherty EL, et al. Surge capacity mechanical ventilation. Respir Care 2008 Jan;53(1):78-90 [Abstract]

* Breiman RF, Nasidi A, Katz MA, et al. Preparedness for highly pathogenic avian influenza pandemic in Africa. (Perspective) Emerg Infect Dis 2007 Oct:13(10):1453-8 [Full text]

* Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7 [Full text]

* Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in healthcare settings. Clin Infect Dis 2003 Oct 15;37(8):1094-101 [Abstract]

* Bright RA, Carter DM, Crevar CJ, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008 Jan 30;3(1):e1501 [Full text]

* Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10) [Full text]

* Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10):e401 [Full text]

* Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis 2008 Aug;14(8) (published online Jul 18) [Full text]

* Brundage JF. Cases and deaths during influenza pandemics in the United States. Am J Prev Med 2006 Sep;31(3):252-6 [Abstract]

* Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006 May;6(5):303-12 [Abstract]

* Buchholz U, Altmann D, Sagebiel D, et al. Stockpiling of anti-influenza drugs in private households: a survey in Germany. Eurosurveillance Weekly 2007 Jan 25;12(1):E070125.4 [Full text]

* Buehler JW, Craig AS, Del Rio C, et al. Critical issues in responding to pandemic influenza. (Conference Summary) Emerg Infect Dis 2006 Jul;12(7) [Full text]

* Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51 [Abstract]

* Caley P, Becker NG, Philp DJ. The waiting time for inter-country spread of pandemic influenza. PLoS One 2007 Jan;2(1):e143 [Full text]

* Caley P, Philp DJ, McCracken K. Quantifying social distancing arising from pandemic influenza. J R Soc Interface 2007 (published online Oct 4) [Full text]

* California Association of Health Facilities (CAHF). Pandemic influenza workbook for long term care providers. Aug 2007 [Full text]

* Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA 2005 Feb 23;293(8):987-97 [Astract]

* Camitz M, Liljeros F. The effect of travel restrictions on the spread of a moderately contagious disease. BMC Med 2006;4(32) (published online Dec 14) [Abstract]

* Campbell JD. Pandemic flu vaccine: are we doing enough? Clin Pharmacol Ther 2007 Dec;82(6):633-5 [Full text]

* Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol 2004 Aug;33(4):393-404 [Abstract]

* Carrat F, Luong J, Lao H, et al. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med 2006;4(26) (published online Oct 23) [Full text]

* Carter NJ, Plosker GL. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) (Prepandrix): a review of its use as an active immunization against influenza A subtype H5N1 virus. BioDrugs 2008;22(5):279-82 [Abstract]

* Casanova L, Alfano-Sobsey E, Rutala WA, et al. Virus transfer from personal protective equipment to healthcare employees' skin and clothing. Emerg Infect Dis 2008 Aug (published online Jun 24) [Full text]

* Cauchemez S, Valleron AJ, Boelle PY, et al. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature 2008 Apr 10;452(7188):750-4 [Abstract]

* CDC. A commentary on the JAMA study's interpretation of the influenza experiences in New York City and Chicago, 1918-19. Jan 17, 2008 [Full text]

* CDC. CDC influenza pandemic operation plan (OPLAN). Released Dec 20, 2006 [Full text]

* CDC. Increased antiviral medication sales before the 2005-06 influenza season: New York City. MMWR 2006 Mar 17;55(10):277-9 [Full text]

* CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses. Excerpted from draft: Biosafety in microbiological and biomedical laboratories. Ed 5. May 3, 2005 [Full text]

* CDC. Interim guidance for airline flight crews and persons meeeting passengers arriving from areas with avian influenza. Published Feb 18, 2004; updated frequently [Web page]

* CDC. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States--early, targeted, layered use of nonpharmaceutical interventions. Released Feb 1, 2007 [Full text]

* CDC. Interim public health guidance for the use of facemasks and respirators in non-occupational community settings during an influenza pandemic. Released May 3, 2007 [Full text]

* CDC. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza [Webpage]

* CDC. Lab diagnosis. [Webpage]

* CDC. New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian lineage). MMWR 2006 Feb 3;55(Early release):1 [Full text]

* CDC. Pandemic influenza: progress made and challenges ahead. Jan 24, 2007, statement by Director Julie L. Gerberding, MD, MPH, before US Senate subcommittee [Full text]

* CDC. Plan now to be ready for the next flu pandemic. Aug 2008 fact sheet [Full text]

* CDC. Public health preparedness: mobilizing state by state. Feb 20, 2008 [Full text]

* CDC. Q & A on Executive Order adding potentially pandemic influenza viruses to list of quarantinable diseases. Apr 11, 2005 [Full text - See Executive Order under "White House" below]

* CDC. Respiratory hygiene/cough etiquette in healthcare settings [Webpage]

* CDC. Select Agent Program [Webpage]

* CDC. Social distancing law project. 2008 [Full text]

* CDC. The next flu pandemic: what to expect. Aug 2008 fact sheet [Full text]

* CDC. Update on influenza A(H5N1) and SARS: Interim recommendations for enhanced U.S. surveillance, testing, and infection controls [Full text]

* CDC. Updated interim guidance for laboratory testing of persons with suspected infection with avian influenza A (H5N1) virus in the United States. Jun 7, 2006 [Full text]

* CDC. What you should know about using facemasks and respirators during a flu pandemic. Released May 3, 2007 [Full text]

* CDC/HICPAC. Guideline for isolation precautions in hospitals, 1994 [Webpage]

* CDC/HICPAC. Guidelines for Preventing Healthcare Associated Pneumonia, 2003 [Webpage]

* Chakraborti C. Pandemic management and developing world bioethics: bird flu in West Bengal. Dev World Bioeth 2008 (published online Aug 11) [Abstract]

* Chamberlain A, Gronvall GK. Immune-boosting adjuvants. Biosecur Bioterror 2007 Sep;5(3):202-5 [Extract]

* Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005 Nov 11;6(1) [Full text]

* Chen GW, Chang SC, Mok CK, et al. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 2006 Sep;12(9):1353-60 [Full text]

* Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci 2006 (published online Feb 10) [Abstract]

* Chen H, Subbarao K, Swayne D, et al. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. Vaccine 2003 May 16;21(17-18):1983-8 [Abstract]

* Chen J, Chen SCY, Stern P, et al. Genetic strategy to prevent influenza virus infections in animals. J Infect Dis 2008 Feb 15;197(S1):S25-8 [Abstract]

* Chen LM, Davis CT, Zhou H, et al. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog 2008 May 23;4(5):e1000072 [Full text]

* Cheng X, Wu C, He J, et al. Serological and genetic characterization analyses of a highly pathogenic influenza virus (H5N1) islolated from an infected man in Shenzhen. J Med Virol 2008 Apr 21;80(6):1058-64 [Abstract]

* Chesser A, Ablah E, Hawley SR, et al. Preparedness needs assessment in a rural state: themes derived from public focus groups. Biosecur Bioterror 2006 Dec;4(4):376-83 [Abstract]

* Choi YK, Ozaki H, Webby RJ, et al. Continuing evolution of H9N2 influenza viruses in southeastern China. J Virol 2004 Aug;78(16):8609-14 [Abstract]

* Chowell G, Bettencourt LMA, Johnson N, et al. The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc R Soc B 2007 (published online Dec 20) [Abstract]

* Chowell G, Nishiura H, Bettencourt LMA. Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface 2006 (published online Oct 12) [Abstract]

* Christian MD, Hawryluck L, Wax RS, et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 2006 Nov 21;175(11):1377-81 [Full text]

* Christophersen OA, Haug A. Why is the world so poorly prepared for a pandemic of hypervirulent avian influenza? Microb Ecol Health Dis 2006 Dec;18(3-4):113-32 [Abstract]

* Chutinimitkul S, Songserm T, Amonsin A, et al. New strain of influenza A virus (H5N1), Thailand. (Letter) Emerg Infect Dis 2007 Mar;13(3) (published online Feb 15) [Full text]

* Coiras MT, Perez-Brena P, Garcia ML, et al. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J Med Virol 2003 Jan;69(1):132-44 [Abstract]

* Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet 2006 (Published online Aug 22) [Abstract]

* Coker R. UK preparedness for pandemic influenza. BMJ 2007 May 12;334(7601):965 [Extract]

* Coleman CH, Reis A. Potential penalties for health care professionals who refuse to work during a pandemic. (Commentary) JAMA 2008 Mar 26;299(12):1471-3 [Extract]

* Colina R, Costa-Mattioli M, Dowling RJO, et al. Translational control of the innate immune response through IRF-7. Nature 2008 Mar 20;452(7185):323-8 (published online Feb 13) [Abstract]

* Colizza V, Barrat A, Barthelemy M, et al. Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions. PLoS Med 2007 Jan 23;4(1):e13 [Full text]

* Colizza V, Barrat A, Barthelemy M, et al. The role of the airline transportation network in the prediction and predictability of global epidemics. Proc Natl Acad Sci 2006 (published online Feb 3) [Abstract]

* Collignon PJ, Carnie JA. Infection control and pandemic influenza. Med J Aust 2006 Nov 20;185(10 suppl):S54-7 [Full text]

* Collins N, Litt J, Moore M, et al. General practice: professional preparation for a pandemic. Med J Aust 2006 Nov 20;185(10 suppl):S66-9 [Full text]

* Collins PJ, Haire LF, Lin YP, et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008 Jun 26;453(7199):1258-61 [Abstract]

* Conenello GM, Palese P. Influenza A virus PB1-F2: a small protein with a big punch. (Editorial) Cell Host Microbe 2007 Oct 10;2(4):207-9 [Abstract]

* Conenello GM, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007 Oct 5;3(10):e141 [Full text]

* Congressional Budget Office. US policy regarding pandemic-influenza vaccines. Released Sep 15, 2008 [Full text]

* Conly JM. Personal protective equipment for preventing respiratory infections: What have we really learned? (Commentary) CMAJ 2006 Aug 1;175(3):263-4 [Full text]

* Conseil A, Mounier-Jack S, Coker R. Business continuity planning and pandemic influenza in Europe: an analysis of independent sector and national governments' guidance. Report from London School of Hygiene & Tropical Medicine released Jun 4, 2008 (but dated Mar 31) [Link to full text]

* Cooper B. Influenza pandemic scenario analysis report: could a pandemic be contained using antiviral agents? Eurosurveillance Weekly 2004 May 6;8(19) [Full text]

* Cooper BS, Pitman RJ, Edmunds WJ, et al. Delaying the international spread of pandemic influenza. PLoS 2006 Jun;3(6) [Full text]

* Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000 Feb;51:407-21 [Abstract]

* Cox NJ, Tamblyn SE, Tam T. Influenza pandemic planning. Vaccine 2003 May 1;21(16):1801-3 [Abstract]

* Crawford PC, Dubovi EJ, Castleman WL, et al. Transmission of equine influenza virus to dogs. Science 2005 Oct 21;310(5747):482-5 [Abstract]

* CRS (Congressional Research Service). Pandemic influenza: an analysis of state preparedness and response plans. Released Sep 24, 2007 [Full text]

* CSTE. Influenza preparedness state plans [Webpage]

* Cummings KJ, Cox-Ganser J, Riggs MA, et al. Respirator donning in post-hurricane New Orleans. Emerg Infect Dis 2007 May;13(5) (published online Mar 30) [Full text]

* Cunha BA. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 2004 Mar;18(1):141-5 [Abstract]

* Curran MS, Ellis JS, Wreghitt TG, et al. Establishment of a UK National Influenza H5 Laboratory Network. J Med Microbiol 2007 Oct;56(10):1263-7 [Full text]

* Davey VJ, Glass RJ, Min HJ, et al. Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance. PLoS ONE 2008 Jul 2;3(7):e2606 [Full text]

* Davey VJ, Glass RJ. Rescinding community mitigation strategies in an influenza pandemic. Emerg Infect Dis 2008 Mar;14(3) (published online Feb 4) [Full text]

* Dawes M. Using physical barriers to reduce the spread of respiratory viruses. (Editorial) BMJ 2008 Jan 12;336(7635):55-6 [Abstract]

* De Clercq E. Antiviral agents active against influenza A viruses. Nature Rev Drug Disc 2006 Dec;5(12):1015-25 [Abstract]

* De Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. (Letter) Nat Med 2006 Oct:12(10):1203-7 [Abstract]

* De Jong MD, Thanh TT, Khank TH, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005 Dec 22;353(24):2667-72 [Full text]

* de Zwart O, Veldhuijzen IK, Elam G, et al. Avian influenza risk perception, Europe and Asia. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 10) [Full text]

* Debarre F, Bonhoeffer S, Regoes RR. The effect of population structure on the emergence of drug resistance during influenza pandemics. J R Soc Interface 2007 Oct 22;4(16):893-906 [Abstract]

* Democratis J, Pareek M, Stephenson I. Use of neuraminidase inhibitors to combat pandemic influenza. J Antimicrob Chemother 2006 (published online Sep 6) [Abstract]

* Department of Health & Children (Ireland). Influenza Pandemic Preparedness in Ireland Joint Assessment Report 2007. Released Nov 26 [Full text]

* Department of Health (UK). Exercise Winter Willow: lessons identified. Aug 30, 2007 [Full text]

* Department of Health (UK). Links to reports on UK's national plan, including guidance for hospitals, ambulance services, primary care, and adult social care as well as ethical considerations, released Nov 22 [Full text]

* Department of Health (UK). Pandemic flu: a national framework for responding to an influenza pandemic. Released Nov 22, 2007 [Full text]

* Department of Health (UK). Pandemic influenza: guidance on preparing mental health services in England. Jul 2, 2008 [Full text]

* Department of Health (UK). Pandemic influenza: surge capacity and prioritisation in health services (draft for comment). Sep 4, 2008 [Full text]

* Department of Health (UK). Responding to pandemic influenza: the ethical framework for policy and planning. Released Nov 22, 2007 [Full text]

* Department of the Treasury (US), FBIIC, FSSCC, et al. The FBIIC/FSSCC pandemic flu exercise of 2007 after action report. Released Jan 24, 2008 [Full text]

* Devereaux A, Christian MC, Dichter JR, et al. Summary of suggestions from the Task Force for Mass Critical Care Summit, January 26-27, 2007. Chest 2008 May;133(5 suppl):S1-7 [Full text]

* DHS. Creating a culture of preparedness among schools. Released Oct 30, 2007 [Full text]

* DHS. National infrastructure protection plan. Released Jun 30, 2006 [Links to full text & executive summary]

* DHS. National preparedness guidelines. Released Sep 13, 2007 [Full text]

* DHS. Nationwide plan review phase 2 report. Jun 16, 2006 [Full text]

* Dimmock NJ, Rainsford EW, Scott PD, et al. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 2008 Sep;82(17):8570-78 [Abstract]

* DiNapoli JM, Yang L, Suguitan A Jr, et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza. J Virol 2007 Nov;81(21):11560-8 [Abstract]

* Dinh PN, Long HT, Tien NTK, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 2006;12(12) (published online Oct 25) [Full text]

* DoD (Dept of Defense). Pandemic influenza: clinical guidelines for the military health system. Released May 17, 2007 [Full text]

* DoD. Department of Defense implementation plan for pandemic influenza. Released May 9, 2007 [Full text]

* Dolin R. Influenza: interpandemic as well as pandemic disease. (Perspective) N Engl J Med 2005 Dec 15;353(24):2535-7 [Extract]

* Doolittle A. Ill prepared: pandemic flu could cripple government. Federal Times 2007 Oct 15 [Full text]

* DOT (US Department of Transportation). Sub-sector pandemic influenza planning guidelines (for aviation, highway and motor carrier, maritime, mass transit, and railroad sub-sectors). Released Apr 1, 2008, as annexes to DHS preparedness guidelines [Web site, with links to PDFs]

* Dowdle WR. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis 2006 Jan;12(1):34-9 [Full text]

* Draper H, Wilson S, Ives J, et al. Healthcare workers' attitudes towards working during pandemic influenza: a multimedia study. BMC Public Health 2008 Jun 2;8:192 [Abstract]

* Du QS, Wang SQ, Chou KC. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Comm 2007 (published online Aug 13) [Abstract]

* Duerr HP, Brockmann SO, Piechotowski I, et al. Influenza pandemic intervention planning using InfluSim: pharmaceutical and non-pharmaceutical interventions. BMC Infect Dis 2007;7:76 (published online Jul 13) [Full text]

* Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006 Nov 20;185(10 suppl):S48-53 [Full text]

* Edwards JC, Kang J, Silenas R. Promoting regional disaster preparedness among rural hospitals. J Rural Health 2008 Summer;24(3):321-5 [Abstract]

* Ehrlich HJ, Muller M, Oh HML, et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008 Jun 12;358(24):2573-84 [Full text]

* Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303 [Abstract]

* Eisenman DP, Cordasco KM, Asch S, et al. Disaster planning and risk communication with vulnerable communities: lessons from Hurricane Katrina. Am J Public Health 2007 (published online Apr 5) [Abstract]

* Emanuel E, Wertheimer A. Public health: who should get influenza vaccine when not all can? Science 2006 May 12;312(5775):854-5 [Summary with full-text link for subscribers]

* Enserink M. Influenza: tense meeting produces some hope for flu-sharing deal. Science 2007 Nov 30;318(5855):1361 [Abstract]

* Epico working group. Modelling scenarios of diffusion and control of pandemic influenza, Italy. Eurosurveillance Weekly 2007 Jan 4;12(1):E070104.2 [Full text]

* Epstein JM, Goedecke DM, Yu F, et al. Controlling pandemic flu: the value of international air travel restrictions. PLoS One 2007 May;2(5):e401 [Full text]

* Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006 Jan 1;193(1):49-53 [Abstract]

* Ethics in the Worst of Times: Rationing to Protect the Public's Health during a Severe Influenza Pandemic Streaming video of panel discussion Jun 5, 2008, from Minnesota Dept of Health and University of Minnesota Center for Public Health Preparedness [http://cpheo.sph.umn.edu/cpheo/ethics/home.html]

* European Centre for Disease Prevention and Control (ECDC). Technical report: Expert advisory groups on human H5N1 vaccines: public health and operational questions. Released Sep 20, 2007 [Full text]

* European Centre for Disease Prevention and Control (ECDC). Technical report: Expert advisory groups on human H5N1 vaccines: scientific questions. Released Sep 20, 2007 [Full text]

* European Centre for Disease Prevention and Control (ECDC). Technical report: pandemic influenza preparedness in the EU. Released Feb 22, 2007 [Full text]

* European Centre for Disease Surveillance and Control. Highly pathogenic avian influenza A/H5N1--update and overview of 2006. Eurosurveillance Weekly 2006 Dec 21;11(12):E061221.1 [Full text]

* European Commission. Influenza and how the EU should respond to a pandemic. Press release, Mar 31, 2004 [Full text]

* European Commission. Timeline of actions by the EC on avian influenza and human flu pandemic preparedness. Aug 25, 2005 [Full text]

* Eurosurveillance Editorial Team, Paget J. Considerable progress in European preparations for a potential influenza pandemic. Eurosurveillance Weekly 2004 Dec 23;8(52) [Full text]

* FAO. Bird flu virus in Europe--a hidden danger. Oct 25, 2007, release [Full text]

* FAO. Enhancing control of highly pathogenic avian influenza in developing countries through compensation: issues and good practice. Nov 27, 2006 [Full text]

* FAO. Potential risk of highly pathogenic avian influenza (HPAI) spreading through wild water bird migration. FAOAIDEnews 2005 Sep 1;33 [Full text]

* FAO. Update on the avian influenza situation. AIDE News 2006 Jun 19, Issue no. 40 [Full text]

* Fasina FO, Bisschop SP, Webster RG. Avian influenza H5N1 in Africa: an epidemiological twist. Lancet Infect Dis 2007 Nov;7(11):696-7 [Full text]

* Fauci AS. Pandemic influenza threat and preparedness. Emerg Infect Dis 2006 Jan;12(1):73-7 [Full text]

* Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006 Nov 1;194(suppl 2):S73-6 [Abstract]

* FDA. FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. Apr 17, 2007, press release [Full text]

* FDA. FDA clears first respirators for use in public health medical emergencies. May 8, 2007, news release [Full text]

* FDA. FDA pandemic influenza preparedness strategic plan. Released Mar 14, 2007 [Full text]

* FDA. Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines. May 31, 2007 [Full text]

* Fedson DS, Dunnill P. New approaches to confronting an imminent influenza pandemic. (Commentary) Perm J 2007 summer;11(3):63-9 [Full text]

* Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 2008 (published online Apr 16) [Abstract]

* Fedson DS. Pandemic influenza and the global vaccine supply. Clin Infect Dis 2003 Jun 15;36(12):1552-61 [Abstract]

* Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. (Viewpoints) Clin Infect Dis 43(2):199-205 [Abstract]

* Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3 [Full text]

* Fedson DS. Vaccination for pandemic influenza: a six point agenda for interpandemic years. Pediatr Infect Dis J 2004 Jan;23(1 Suppl):S74-7 [Abstract]

* Fell G. Preparedness of residential and nursing homes for pandemic flu. J Public Health 2008 Mar;30(1):99-102 [Abstract]

* Ferguson N. Poverty, death, and a future influenza pandemic. Lancet 2006 Dec 23;368(9554);2187-8 [Full text]

* Ferguson NM, Cummings DA, Fraser C, et al. Strategies for mitigating an influenza pandemic. (Letter) Nature 2006 (published online Apr 26) [Abstract]

* Ferguson NM, Cummings DAT, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005 Sep 8;437:209-14 [Abstract]

* Fick J, Lindberg RH, Tysklind M, et al. Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS ONE 2007 Oct 3;2(10):e986 [Full text]

* Fidler D. Influenza virus samples, international law, and global health diplomacy. Emerg Infect Dis 2008 Jan;14(1):88-94 [Full text]

* Finkelstein DB, Mukatira S, Mehta PK, et al. Persistent host markers in pandemic and H5N1 influenza viruses. J Virol 2007 (published online Jul 25) [Abstract]

* Florida Dept of Agriculture & Consumer Services. Pandemic influenza: agriculture planning toolkit. Released Apr 28, 2008 [Full text]

* Forsberg White L, Pagano M. Transmissibility of the influenza virus in the 1918 pandemic. PLoS ONE 2008 Jan 30;3(1):e1498 [Full text]

* Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005 Mar;79(5):2814-22 [Abstract]

* Fraser C. Influenza pandemic vaccines: spread them thin? PLoS Med 2007 Jun;4(6):e228 [Full text]

* FSSCC (Financial Services Sector Coordinating Council for Critical Infrastructure Protection and Homeland Security). Statement on preparations for "avian flu." Jan 24, 2006 [Full text]

* Gambotto A, Barrat-Boyes SM, de Jong MD, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008 Apr 25;371(9622):1464-75 [Abstract]

* Gani R, Hughes H, Fleming D, et al. Potential impact of antiviral use on hospitalizations during influenza pandemic. Emerg Infect Dis 2005 Sep;11(9) [Full text]

* GAO (US Government Accountability Office). Emergency management: observations on DHS's preparedness for catastrophic disasters. GAO-08-868T. Released Jun 11, 2008 [Full text]

* GAO (US Government Accountability Office). Emergency preparedness: states are planning for medical surge, but could benefit from shared guidance for allocating scarce medical resources. GAO-08-668. Released Jul 14, 2008 (but dated Jun 2008) [Full text]

* GAO (US Government Accountability Office). Financial market preparedness: significant progress has been made, but pandemic planning and other challenges remain. Report released May 1, 2007 [Full text]

* GAO (US Government Accountability Office). Homeland Security: observations on DHS and FEMA efforts to prepare for and respond to major and catastrophic disasters and address related recommendations and legislation. GAO-07-1142T. Jul 31, 2007 [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: DOD combatant commands' preparedness efforts could benefit from more clearly defined roles, resources, and risk mitigation. GAO-07-696. Jul 20, 2007 [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: efforts to forestall onset are under way; identifying countries at greatest risk entails challenges. Released Jun 20, 2007 [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: efforts under way to address constraints on using antivirals and vaccines to forestall a pandemic. GAO-08-92. Released Jan 22, 2008 (but dated Dec 21, 2007) [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: federal agencies should continue to assist states to address gaps in pandemic planning. GAO-08-539. Released Jul 21, 2008 (but dated Jun 19) [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: federal executive boards' ability to contribute to pandemic preparedness. Senate testimony Sep 28, 2007 [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: further efforts are needed to ensure clearer federal leadership roles and an effective national strategy. GAO-07-781. August 14, 2007 [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: HHS needs to continue its actions and finalize guidance for pharmaceutical interventions. GAO-08-671. Sep 30, 2008 [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: opportunities exist to address critical infrastructure protection challenges that require federal and private sector coordination. GAO-08-36. Released Oct 31, 2007 [Full text]

* GAO (US Government Accountability Office). Influenza pandemic: opportunities exist to clarify federal leadership roles and improve pandemic planning. Testimony before the Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology, House Committee on Homeland Security. GAO-07-1257T. September 26, 2007 [Full text]

* Gao W, Soloff AD, Lu X, et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006 Feb;80(4):1959-64 [Abstract]

* Garcia-Sastre A, Whitley RJ. Lessons learned from reconstructing the 1918 influenza pandemic. J Infect Dis 2006 Nov 1;194(suppl 2):S127-32 [Abstract]

* Garcia-Sastre A. Antiviral response in pandemic influenza viruses. Emerg Infec Dis 2006 Jan;12(1):44-7 [Full text]

* Garrett L, Fidler DP. Sharing H5N1 viruses to stop a global influenza pandemic. (Commentary) PLoS Med 2007 (published online Nov 20) [Full text]

* Garrett L. The next pandemic? Foreign Aff 2005 Jul/Aug;84(4) [Excerpt]

* Garrett TA. Pandemic economics: the 1918 influenza and its modern-day implications. Review (Federal Reserve Bank of St Louis) 2008 Mar/Apr;90(2):74-94 [Full text]

* Gatrad AR, Shafi S, Memish ZA